Helminth-Associated Systemic Immune Activation and HIV Co-receptor Expression: Response to Albendazole/Praziquantel Treatment

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  Chachage, Mkunde ^a   Podola, Lilli ^a,b   Clowes, Petra ^a,b   Nsojo, Anthony ^a   Bauer, Asli ^a,b   Mgaya, Onesmo ^a   Kowour, Dickens ^a   Froeschl, Guenter ^b   Maboko, Leonard ^a   Hoelscher, Michael ^b,c   Saathoff, Elmar ^b,c   Geldmacher, Christof ^b,c  

^a National Institute for Medical Research (NIMR) Mbeya Medical Research Centre   (Tanzania)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c German Centre for Infection Research (DZIF)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CD27 ANTIGEN; CD38 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; PRAZIQUANTEL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASCARIASIS; BLOOD SAMPLING; CELL DIFFERENTIATION; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EOSINOPHIL COUNT; FEMALE; FLOW CYTOMETRY; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; TRICHURIASIS;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIGENS, CD; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HELMINTHIASIS; HELMINTHS; HIV INFECTIONS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PRAZIQUANTEL; RECEPTORS, CCR5; RECEPTORS, HIV; TANZANIA; YOUNG ADULT;

EID: 84897454403     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002755     Document Type: Article

References (49)

1. Bentwich Z, Kalinkovich A, Weisman Z, (1995) Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16: 187-191.
2. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
3. Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, et al. (1998) Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 114: 414-421.
4. Kalinkovich A, Borkow G, Weisman Z, Tsimanis A, Stein M, et al. (2001) Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 100: 107-117.
5. Secor WE, Shah A, Mwinzi PMN, Ndenga BA, Watta CO, et al. (2003) Increased Density of Human Immunodeficiency Virus Type 1 Coreceptors CCR5 and CXCR4 on the Surfaces of CD4+ T Cells and Monocytes of Patients with Schistosoma mansoni Infection. Infect Immun 71: 6668-6671.
6. Shapira-Nahor O, Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, et al. (1998) Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 12: 1731-1733.
7. Mkhize-Kwitshana ZL, Taylor M, Jooste P, Mabaso ML, Walzl G, (2011) The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa. BMC Infect Dis 11: 273.
8. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer FA, et al. (2009) Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis 199: 1318-1322.
9. Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, et al. (2005) Low-Level CD4+ T Cell Activation Is Associated with Low Susceptibility to HIV-1 Infection. J Immunol 175: 6117-6122.
10. Bégaud E, Chartier L, Marechal V, Ipero J, Léal J, et al. (2006) Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3: 35.
11. EMINI Project (n.d.). Available: http://www.mmrp.org/projects/cohort-studies/emini.html. Accessed 30 August 2013.
12. Moore JP, Kitchen SG, Pugach P, Zack JA, Liebert MA, et al. (2004) The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 20: 111-126.
13. Regoes RR, Bonhoeffer S, (2005) The HIV coreceptor switch: a population dynamical perspective. Trends Microbiol 13: 269-277.
14. Ribeiro RM, Hazenberg MD, Perelson AS, Davenport MP, (2006) Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy. J Virol 80: 802-809.
15. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-759.
16. Picker LJ, Hagen SI, Lum R, Reed-Inderbitzin EF, Daly LM, et al. (2004) Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med 200: 1299-1314.
17. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, et al. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746-754.
18. Geldmacher C, Koup RA, (2012) Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection. Trends Immunol 33: 207-214.
19. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.
20. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
21. Faulkner H, Turner J, Kamgno J, Pion SD, Boussinesq M, et al. (2002) Age- and infection intensity-dependent cytokine and antibody production in human trichuriasis: the importance of IgE. J Infect Dis 185: 665-672.
22. Turner JD, Jackson J a, Faulkner H, Behnke J, Else KJ, et al. (2008) Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J Infect Dis 197: 1204-1212.
23. Borkow G, Leng Q, Weisman Z, Stein M, Galai N, et al. (2000) Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 106: 1053-1060.
24. King CL, Medhat A, Malhotra I, Nafeh M, Helmy A, et al. (1996) Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 156: 4715-4721.
25. Gaze S, McSorley HJ, Daveson J, Jones D, Bethony JM, et al. (2012) Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog 8: e1002520.
26. George PJ, Anuradha R, Kumar NP, Kumaraswami V, Nutman TB, et al. (2012) Evidence of microbial translocation associated with perturbations in T cell and antigen-presenting cell homeostasis in hookworm infections. PLoS Negl Trop Dis 6: e1830.
27. Jovanovic D V, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513-3521.
28. Ascher MS, Sheppard HW, (1988) AIDS as immune system activation: a model for pathogenesis. Clin Exp Immunol 73: 165-167.
29. Giorgi J V, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
30. Giorgi J V, Lyles RH, Matud JL, Yamashita TE, Mellors JW, et al. (2002) Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346-355.
31. Hazenberg MD, Stuart JWTC, Otto SA, Borleffs JCC, Charles AB, et al. (2000) T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART) T-cell division in human immunodeficiency virus. Blood 95: 249-255.
32. Hazenberg MD, Otto SA, Van-Benthem BHB, Roos MTL, Coutinho RA, et al. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888.
33. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187: 1534-1543.
34. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, et al. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR. J Acquir Immune Defic Syndr Hum Retrovirol 16: 83-92.
35. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
36. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 6: e1001052.
37. Broadhurst MJ, Ardeshir A, Kanwar B, Mirpuri J, Gundra UM, et al. (2012) Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog 8: e1003000.
38. Onguru D, Liang Y, Griffith Q, Nikolajczyk B, Mwinzi P, et al. (2011) Human schistosomiasis is associated with endotoxemia and Toll-like receptor 2- and 4-bearing B cells. Am J Trop Med Hyg 84: 321-324.
39. Löscher T, Saathoff E, (2008) Eosinophilia during intestinal infection. Best Pract Res Clin Gastroenterol 22: 511-536.
40. Leder K, Weller PF, (2000) Eosinophilia and helminthic infections. Baillieres Best Pract Res Clin Haematol 13: 301-317.
41. Keiser J, Utzinger J, (2008) Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 299: 1937-1948.
42. Knopp S, Mohammed KA, Speich B, Hattendorf J, Khamis IS, et al. (2010) Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial. Clin Infect Dis 51: 1420-1428.
43. Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, et al. (2003) Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol 132: 113-119.
44. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125.
45. Orendi JM, Bloem a C, Borleffs JC, Wijnholds FJ, de Vos NM, et al. (1998) Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 178: 1279-1287.
46. Xiao J, Qian K, Cao Q, Qiu C, Qiu C, et al. (2011) HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy. Chin Med J (Engl) 124: 2340-2346.
47. Sattentau QJ, Clapham PR, Weiss RA, Beverley PC, Montagnier L, et al. (1988) The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 2: 101-105.
48. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
49. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.